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nts are secreted signaling molecules that can
transduce their signals through several different
pathways. Wnt-5a is considered a noncanonical
 
Wnt as it does not signal by stabilizing 
 
 
 
-catenin in many
 
biological systems. We have uncovered a new noncanonical
pathway through which Wnt-5a antagonizes the canonical
W
 
Wnt pathway by promoting the degradation of 
 
 
 
-catenin.
This pathway is Siah2 and APC dependent, but GSK-3 and
 
 
 
-TrCP independent. Furthermore, we provide evidence that
Wnt-5a also acts in vivo to promote 
 
 
 
-catenin degradation
in regulating mammalian limb development and possibly
in suppressing tumor formation.
 
Introduction
 
Wnts are secreted proteins that control diverse developmental
 
processes such as gastrulation, limb, and CNS development
(Wodarz and Nusse, 1998; Peifer and Polakis, 2000; Thorpe
et al., 2000; Huelsken and Birchmeier, 2001). Recent studies
have also shown that Wnt signaling may regulate the main-
tenance and differentiation of stem cells (Taipale and
Beachy, 2001; Moon et al., 2002). In humans, inappropriate
 
activation of the canonical Wnt signaling pathway is associated
with a high frequency of tumors in specific tissues such as
the intestine, liver, skin, and mammary gland (Taipale and
Beachy, 2001; van Noort and Clevers, 2002).
19 different Wnt genes have been identified in the mouse
and human genomes (http://www.stanford.edu/~rnusse/
wntwindow.html) and they signal through either the canon-
ical pathway or at least two different noncanonical pathways
(Kuhl et al., 2000b; Niehrs, 2001; Winklbauer et al., 2001).
 
The canonical Wnt pathway, through which 
 
Drosophila
 
Wingless and vertebrate Wnt-1, 3a, and 8 transduce their
signals, contains many evolutionarily conserved cellular
components and plays a pivotal role in controlling cell pro-
liferation and differentiation. Central to this pathway is the
 
regulation of 
 
 
 
-catenin activity, which depends on its pro-
tein abundance and nuclear localization. In the absence of
 
Wnt, glycogen synthase kinase 3 (GSK-3) phosphorylates
 
 
 
-catenin, which allows 
 
 
 
-TrCP, an F-box protein in the E3
ubiquitin ligase complex, to bind and tag 
 
 
 
-catenin for pro-
teasome-mediated degradation. When the Wnt ligand binds
to its coreceptors Frizzled and LRP5/6, Dishevelled is acti-
vated and suppresses GSK-3 activity. As a result, 
 
 
 
-catenin is
 
not phosphorylated and remains free from 
 
 
 
-TrCP–mediated
degradation. The accumulated 
 
 
 
-catenin binds the tran-
scription factor of the LEF/TCF family and converts them
from repressors to activators, which triggers downstream
gene transcription (Peifer and Polakis, 2000; Chan and
Struhl, 2002; Bienz and Clevers, 2003). 
 
 
 
-Catenin activity
can also be regulated in the canonical Wnt pathway in a
GSK-3–independent manner as has been shown recently in
 
Drosophila
 
 (Tolwinski et al., 2003). In this pathway, Arrow
(LRP5/6) recruits Axin to the membrane and this interac-
tion leads to Axin degradation upon canonical Wnt signal-
ing. As a consequence, 
 
 
 
-catenin is no longer bound by
Axin, resulting in reduced 
 
 
 
-catenin degradation and cyto-
plasmic sequestration. Thus, canonical Wnt signaling controls
gene expression by allowing 
 
 
 
-catenin to accumulate when
Wnts are present and by reducing nuclear 
 
 
 
-catenin levels
when Wnts are absent.
 
The canonical Wnt pathway is highly susceptible to al-
 
terations of 
 
 
 
-catenin protein stability. Mutations that in-
crease 
 
 
 
-catenin protein levels result in constitutive activa-
tion of this pathway, which, in turn, leads to cell fate
changes during development and tumor formation in
adult animals (Wodarz and Nusse, 1998; Peifer and Po-
lakis, 2000). One of the strategies that a cell uses to com-
bat this deleterious condition is to utilize additional regu-
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latory pathways that can modulate the level of 
 
 
 
-catenin.
For instance, 
 
 
 
-catenin induces its own negative regulators
 
Naked
 
 and 
 
Axin2
 
 (Zeng et al., 2000; Jho et al., 2002). It
has also been shown that both phosphorylated and un-
phosphorylated 
 
 
 
-catenin can be targeted for proteasome-
mediated degradation through an alternative E3 ubiquitin
ligase complex that contains APC, Ebi, and Siah1 or 2
(Liu et al., 2001; Matsuzawa and Reed, 2001). This path-
way can be regulated by controlling the transcription of
 
Siah
 
. However, it is unknown whether 
 
Siah
 
 expression is
regulated by Wnt signaling.
Wnt-5a signals through noncanonical pathways in a vari-
ety of assays, which may involve stimulation of intracellular
Ca
 
2
 
 
 
 release and activation of PKC and CaMKII (Sheldahl
et al., 1999; Kuhl et al., 2000b). Wnt-5a has also been sug-
gested to antagonize canonical Wnt activity both in 
 
Xenopus
 
embryos and mammalian cells (Torres et al., 1996; Olson
and Gibo, 1998; Ishitani et al., 2003). However, the under-
lying mechanism is not clear and direct genetic evidence for
this antagonistic interaction is lacking.
Here, we demonstrate that Wnt-5a signaling can antagonize
the canonical Wnt signaling pathway by promoting 
 
 
 
-catenin
degradation. We further show that the 
 
 
 
-catenin degradation
induced by Wnt-5a is independent of phosphorylation by
GSK-3 and involves the induction of 
 
Siah2
 
 expression. We
also find that Wnt-5a–induced 
 
 
 
-catenin degradation does not
require activation of CaMKII or NF-AT. Finally, we demon-
strate through studies of 
 
Wnt-5a
 
 
 
/
 
 
 
 embryos that in vivo, 
 
Wnt-
5a
 
 functions at least in part through promoting 
 
 
 
-catenin deg-
radation. We also provide evidence that 
 
Wnt-5a
 
 may act as an
oncosuppressive gene in the adult gut.
 
Results
 
Wnt-5a antagonizes the canonical Wnt signaling 
pathway by promoting GSK-3–independent 
degradation of 
 
 
 
-catenin
 
To understand the mechanism by which Wnt-5a inhibits
the canonical Wnt signaling, we used a TCF reporter (TOP-
FLASH; Korinek et al., 1997) as a readout for the canonical
Wnt pathway activity in a variety of cell lines. In immortal-
ized human embryonic kidney cells (HEK 293 cells), 
 
Wnt-
3a
 
 expression led to up-regulation of the canonical Wnt ac-
tivity as indicated by the increased luciferase activity (Fig. 1
A). When 
 
Wnt-5a
 
 was cotransfected with 
 
Wnt-3a
 
, we found
that the luciferase activity was largely reduced. Interestingly,
although lower levels of 
 
Wnt-3a
 
 expression (10 and 33 ng)
activated TOPFLASH in a dose-dependent manner, higher
levels of 
 
Wnt-3a
 
 (167 ng–1 
 
 
 
g) resulted in gradually re-
duced stimulation of TOPFLASH activity (Fig. 1 A). How-
ever, inhibition of the canonical Wnt signaling by Wnt-5a
was not simply a result of higher 
 
Wnt
 
 expression. This is be-
cause 
 
Wnt-5a
 
 did not stimulate TOPFLASH when ex-
pressed at both low and high levels (not depicted), and a
very low level of 
 
Wnt-5a
 
 expression (10 ng) inhibited TOP-
FLASH activity stimulated by a low level of 
 
Wnt-3a
 
 expres-
sion (33 ng; Fig. 1 A).
Next, we considered the possibility that Wnt-5a might
suppress canonical Wnt pathway activity through inhibition
of the binding of canonical Wnts with their receptors. If this
were true, Wnt-5a would be unable to suppress the canoni-
cal Wnt pathway activity stimulated by 
 
 
 
-catenin. However,
we found that Wnt-5a strongly suppressed the luciferase ac-
Figure 1. Wnt-5a suppressed canonical Wnt signaling 
activity.  -Catenin/TCF transcriptional activity was indicated 
by TOPFLASH luciferase activity. FOPFLASH, which contains 
mutant LEF/TCF binding sites, was used as a negative control 
for pathway specificity. Luciferase activity was measured 
48 h after transfection and the results are shown as relative 
luciferase activity. The histograms are the average   SD from 
three independent transfections. (A) Wnt-3a activated the 
reporter activity and such activation was gradually inhibited 
by higher doses of Wnt-3a. A low dose of Wnt-5a (67 ng) 
down-regulated the reporter activity induced by different 
doses of Wnt-3a (10 ng–1  g) in 293 cells. The reporter 
activity activated by a low dose of Wnt-3a (33 ng) was inhibited by Wnt-5a in a dose dependent manner (10–167 ng). The mutant reporter 
FOPFLASH did not respond to Wnt-3a or Wnt-5a. (B) Wnt-5a down-regulated the reporter activity induced by  -catenin in 293 cells. (C) 293 
cells were transfected with  -catenin and GFP or Wnt-5a where indicated. Wnt-5a expression led to a decrease in  -catenin protein levels.T
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tivity stimulated by 
 
 
 
-catenin in various cells including 293
cells (Fig. 1 B and not depicted). Thus, the interaction of
Wnt5a signaling and the canonical Wnt pathway lies down-
stream of the receptor–ligand interaction.
Then, we tested whether Wnt-5a inhibited the canonical
Wnt pathway by regulating 
 
 
 
-catenin degradation. In contrast
to what has been reported in a recent publication (Ishitani et
al., 2003), we found that 
 
Wnt-5a
 
 expression led to a signifi-
cant decrease in 
 
 
 
-catenin protein levels in 293 cells (Fig. 1 C),
suggesting that Wnt-5a antagonizes the canonical Wnt path-
way by promoting the degradation of 
 
 
 
-catenin protein.
Because phosphorylation of 
 
 
 
-catenin by GSK-3 followed
by 
 
 
 
-TrCP binding results in 
 
 
 
-catenin degradation, we
then tested whether Wnt-5a promoted 
 
 
 
-catenin degrada-
tion requires GSK-3 or 
 
 
 
-TrCP. We used LiCl to specifi-
cally inhibit GSK-3 (Klein and Melton, 1996). LiCl treat-
ment resulted in the enhancement of TOPFLASH reporter
activity and accumulation of endogenous 
 
 
 
-catenin in 293
cells (Fig. 2, A and C). However, 
 
Wnt-5a
 
 was still able to in-
hibit 
 
 
 
-catenin activity substantially in the presence of LiCl
(Fig. 2 A). In addition, when the activity of 
 
 
 
-TrCP was
blocked by a dominant negative 
 
 
 
-TrCP (
 
  
 
-TrCP), Wnt-
5a was still able to suppress 
 
 
 
-catenin activity (Fig. 2 B).
Consistent with the decrease in TOPFLASH activity, Wnt-
5a signaling reduced endogenous 
 
 
 
-catenin protein levels in
the presence of LiCl and 
 
  
 
-TrCP (Fig. 2 C). These results
indicate that the 
 
 
 
-catenin protein degradation promoted by
 
Wnt-5a
 
 was independent of GSK-3 and 
 
 
 
-TrCP. Therefore,
Wnt-5a might potentially be able to promote the degrada-
tion of two different forms of mutant 
 
 
 
-catenin, which can-
not be phosphorylated by GSK-3 and are constitutively ac-
tive. One mutant, 
 
 
 
-catenin S37A, is a Ser to Ala mutation
that abolishes the GSK-3 dependent phosphorylation of
 
 
 
-catenin at Ser 37, which is required for 
 
 
 
-TrCP binding.
A second mutant, 
 
  
 
-catenin, lacks amino acids 29–48 and
 
contains none of the GSK-3 phosphorylation sites that are
required for 
 
 
 
-catenin degradation (Tetsu and McCormick,
1999). Both mutants stabilized 
 
 
 
-catenin. However, when
they were coexpressed with 
 
Wnt-5a
 
 in 293 cells, we found
that they were destabilized by Wnt-5a (Fig. 2 D), demon-
strating that Wnt-5a functions to inhibit canonical Wnt/
 
 
 
-catenin pathway independently of GSK-3 and 
 
 
 
-TrCP.
 
Wnt-5a promoted 
 
 
 
-catenin degradation does not 
require CaMKII or NF-AT activation
 
Wnt-5a signaling may activate PKC and intracellular Ca
 
2
 
 
 
mobilization to trigger a series of downstream effects includ-
ing activation of NF-AT and CaMKII (Kuhl et al., 2000a;
Saneyoshi et al., 2002). During early 
 
Xenopus
 
 development,
 
Wnt-5a
 
 activates calcineurin, which leads to NF-AT nuclear
localization and increased 
 
 
 
-catenin degradation (Saneyoshi
et al., 2002). To address how Wnt-5a transduces its signal in
mammalian cells, we checked whether Wnt-5a activates NF-
AT transcriptional activity and whether such activation is
required for Wnt-5a–induced  -catenin degradation. We
found that NF-AT transcriptional activity was only weakly
activated by Wnt-5a ( 50%), whereas it was strongly up-
regulated by activated calcineurin ( 300%; Fig. 3 A). In ad-
dition, we found that although activated calcineurin was
able to inhibit the TOPFLASH activity up-regulated by
 -catenin S37A, Wnt-5a had an additive effect in its pres-
ence (Fig. 3 B). Moreover, specific inhibition of calcineurin
by Cyclosporin A (CsA; Crabtree and Olson, 2002) did not
block the inhibitory effect of Wnt-5a on  -catenin activity
and protein stability (Fig. 3, B and D), although it strongly
inhibited NF-AT transcriptional activity (Fig. 3 A) and up-
regulated  -catenin protein level in the absence of Wnt-5a
(Fig. 3 D). These data indicate that the calcineurin–NF-AT
pathway is not the major one mediating the effect of Wnt-5a
on  -catenin degradation in 293 cells. Next, we also exam-
Figure 2. Wnt-5a promoted  -catenin degradation 
through a mechanism independent of GSK-3 and  -TrCP. 
(A) 24 h after transfection, 293 cells were treated with 
40 mM LiCl for 16 h before cells were harvested. LiCl 
treatment up-regulated TOPFLASH reporter activity. 
Wnt-5a suppressed the effect of LiCl. (B) Cells were 
transfected with the indicated plasmids and harvested 
48 h later for luciferase assay.   -TrCP up-regulated the 
TOPFLASH reporter activity and this effect was suppressed 
by Wnt-5a. (C) 293 cells were transfected with the 
indicated plasmids and treated with LiCl as in A. LiCl 
treatment or   -TrCP expression stabilized the endogenous 
 -catenin and Wnt-5a inhibited this effect. (D) Wnt-5a 
promoted the degradation of two mutant stabilized forms 
of  -catenin in 293 cells. Cells were transfected with the 
indicated plasmids and 48 h after transfection, cells were 
harvested for western analysis.T
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ined in 293 cells whether Wnt-5a activated PKC, CaMKII
or JNK, all of which have been implicated in transducing
the noncanonical Wnt-5a signal (Kuhl et al., 2000a; Ya-
manaka et al., 2002). Consistent with what has been shown
before, we found that Wnt-5a signaling led to the activation
of PKC and CaMKII in 293 cells (unpublished data). How-
ever, no significant JNK activation was detected (Fig. 3 C).
In addition, we found that, in contrast to Wnt-5a signaling,
PKC activation led to stabilization of  -catenin as shown
previously (Chen et al., 2000; unpublished data). As an acti-
vated form of CaMKII was able to inhibit TOPFLASH ac-
tivity (Fig. 3 B), we tested whether CaMKII activation is
required for Wnt-5a–induced  -catenin degradation. We
blocked CaMKII activity with a dominant negative CaMKII
(Kuhl et al., 2000a) or KN93 (Rich and Schulman, 1998).
We found that blocking CaMKII activity did not rescue the
TOPFLASH activity or  -catenin protein stability inhibited
by Wnt-5a (Fig. 3, B and D), indicating that CaMKII is not
required in the Wnt-5a signaling pathway for  -catenin deg-
radation. Interestingly, in the absence of Wnt-5a, inhibition
of CaMKII by a dominant negative CaMKII or KN93 also
resulted in the up-regulation of  -catenin protein level (Fig.
3 D). Together, our results indicate that activation of NF-
AT or CaMKII may play a role in promoting  -catenin deg-
radation. However, inhibition of canonical Wnt activity by
Wnt-5a can be mediated by pathways other than the activa-
tion of PKC, NF-AT, and CaMKII in mammalian cells.
Siah2 is induced by Wnt-5a and is involved 
in Wnt-5a–induced  -catenin degradation
To test whether Wnt-5a–induced degradation of  -catenin
S37A is also mediated by proteasome, we used epoxomicin to
block proteasome-mediated protein degradation (Meng et al.,
1999). We found that  -catenin S37A degradation induced
by Wnt-5a was substantially inhibited when the cells were
treated with Epoxomicin (Fig. 4 A). As the Siah–APC–Ebi
E3 ubiquitin ligase complex has been implicated in GSK-3–
independent  -catenin degradation (Liu et al., 2001; Mat-
suzawa and Reed, 2001), we then examined whether Siah ac-
tivity is required for Wnt-5a–induced  -catenin degradation.
We found that both Siah1 and 2 exhibit activities similar to
Wnt-5a in inhibiting canonical Wnt activities in 293 cells
(unpublished data). Moreover, a dominant negative Siah2
( Siah2) was able to rescue the  -catenin activity that had
been suppressed by Wnt-5a (Fig. 4 B). In addition, degrada-
tion of wild-type and an activated form of  -catenin by Wnt-
5a signaling were also suppressed by  Siah1 and  Siah2 (Fig.
4 C and not depicted). Furthermore, we found that, as a re-
sult of deceased degradation of the endogenous  -catenin,
both  Siah1 and  Siah2 up-regulated the TOPFLASH ac-
tivity and this was not inhibited by Wnt-5a (Fig. 4 B). As it
has been shown that Siah-dependent  -catenin degradation
requires APC activity (Liu et al., 2001; Matsuzawa and Reed,
2001), we next examined whether a dominant negative form
of APC ( APC), which has been shown to sequester Siah
proteins, could also block  -catenin degradation induced by
Wnt-5a signaling. We found that indeed both the activity
and protein levels of  -catenin were rescued by  APC (Fig. 4
D). In addition, Wnt-5a hardly inhibited the TOPFLASH
activity up-regulated by  APC when there was no exogenous
 -catenin (Fig. 4 D). All these results demonstrate that Wnt-
5a–induced  -catenin degradation requires functional Siah
and APC.
Next, we investigated whether Wnt-5a might promote
 -catenin degradation by regulating Siah gene expression. We
found that Siah2 was normally expressed at very low levels as
Figure 3. Activation of NF-AT and CaMKII is not required for Wnt-5a–induced  -catenin degradation. Cyclosporin A (CsA) inhibited NF-AT 
reporter activity. Luciferase activity was measured 40 h after transfection. (B) Activated calcineurin (pCN) or CaMKII (ca CaMKII) inhibited the 
TOPFLASH activity stimulated by the mutant  -catenin (S37A). Inhibiting calcineurin–NF-AT pathway by CsA or inhibiting CaMKII by KN93 
did not block Wnt-5a–induced inhibition of TOPFLASH activity in 293 cells. 24 h after transfection with indicated plasmids, CsA or KN93 
were added. After 16 h of incubation with the inhibitors, cells were lysed for luciferase assay. (C) 293 cells were transfected with c-Jun and 
indicated plasmids. JNK activation was detected by anti–phospho-c-Jun (Ser 63) antibodies. Dishevelled, but not Wnt-5a, activated JNK. 
(D) CHO cells were transfected with mutant  -catenin (S37A) and Wnt-5a or GFP where indicated, and then treated with CsA or KN93 to 
inhibit calcineurin or CaMKII, respectively. CsA or KN93 treatment or expression of a dominant negative CaMKII (dn CaMKII) appeared to 
stabilize the mutant  -catenin, but neither treatment inhibited Wnt-5a–induced  -catenin degradation.T
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compared with Siah1, but that only Siah2 expression was in-
duced by Wnt-5a in 293 cells (Fig. 4 E and not depicted).
Although p53 activates the expression of Siah1 and 2 (Liu et
al., 2001 and Fig. 4 E), we found that Wnt-5a did not acti-
vate the transcriptional activity of p53 (Fig. 4 F). These data
suggest that Wnt-5a may promote the degradation of
 -catenin by activating the expression of Siah2, possibly
through a pathway parallel to p53 in 293 cells.
 -Catenin protein is accumulated in the distal limb bud 
of Wnt-5a
 /  embryos
To investigate whether Wnt-5a signaling also antagonizes
the canonical Wnt pathway in vivo, we analyzed the limb
development defects in the Wnt-5a
 /  embryos. Wnt-5a is
strongly expressed in the distal limb bud and its expression
gradually fades proximally (Yamaguchi et al., 1999). In the
Wnt-5a
 /  limb, the distal digits are missing. It has been
shown that this is not due to earlier regression of the apical
ectodermal ridge (AER) or absence of the distal limb mesen-
chyme (Yamaguchi et al., 1999). Consistent with previous
observations, we found that the expression of Sox9, the earli-
est marker for mesenchymal condensation and chondrocyte
differentiation (Zhao et al., 1997), was not detected in the
distal-most cells in the Wnt-5a
 /  limb at 12.5 dpc (Fig. 5
A). These data demonstrate that chondrocyte differentia-
tion, which is required for digit formation, was inhibited be-
fore mesenchymal condensation in the distal limb of the
Wnt-5a
 /  limb. This phenotype is different from that in
the LRP6
 /  limb, in which skeletal elements are missing
along the anterior–posterior axis due to a disrupted AER
(Pinson et al., 2000). As LRP6 is a Wnt coreceptor which
acts specifically in the canonical Wnt pathway (Wehrli et
al., 2000), it appears that Wnt-5a signals predominantly
through a noncanonical Wnt pathway during mouse limb
development. Because canonical Wnt signaling has been
shown to inhibit chondrogenesis (Rudnicki and Brown,
1997), we directly assessed canonical Wnt pathway activity
in the Wnt-5a
 /  mutant limb using TOPGAL transgenic
mice in which LacZ expression is under the control of LEF/
TCF binding sites (DasGupta and Fuchs, 1999). Ectopic
LacZ staining was detected in the distal limb of Wnt-5a
 / /
TOPGAL mice at 12.5 dpc (Fig. 5 B), indicating that ca-
nonical Wnt activity has been elevated to a higher level in
the distal part of the limb in the absence of Wnt-5a activity.
Consistent with this, we found that  -catenin protein level
was higher in Wnt-5a
 /  limbs as compared with wild-type
at 11.5 dpc (Fig. 5 C), suggesting that Wnt-5a signaling also
promoted  -catenin degradation in the developing limb.
Next, we tested whether decreasing the canonical Wnt ac-
tivity by applying a secreted Wnt antagonist could rescue
distal chondrogenesis in the Wnt-5a
 /  limb. We generated
chick embryonic fibroblast (CEF) cells that express a se-
Figure 4. Wnt-5a promoted  -catenin degradation through a mechanism that requires Siah2 and APC. (A)  -catenin degradation in response 
to Wnt-5a was inhibited by the proteasome inhibitor epoxomicin. 293 cells were transfected with indicated plasmids. 38 h after transfection, 
cells were treated with 100 nM epoxomicin for 8 h before they were harvested. (B) A dominant negative Siah2 ( Siah2) blocked Wnt-5a 
mediated inhibition of TOPFLASH activity activated by exogenous  -catenin.  Siah1 or  Siah2 alone also up-regulated TOPFLASH activity 
and this was not inhibited by Wnt-5a. FOPFLASH responded to  Siah1 or  Siah2 very weakly. (C)  Siah2 blocked the degradation of both 
wild-type and mutant  -catenin promoted by Wnt-5a. (D)  APC blocked Wnt-5a–induced inhibition of  -catenin activity and degradation. 
 APC alone also up-regulated TOPFLASH, which was hardly inhibited by Wnt-5a. FOPFLASH did not respond to  APC. (E) RT-PCR was 
performed to detect Siah2 transcript. Expression of Siah2 was induced by Wnt-5a and p53 in 293 cells. (F) Wnt-5a did not activate p53 
transcriptional activity.T
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creted Wnt antagonist Sfrp-2. Sfrp-2 is normally expressed
in the surrounding mesenchyme of newly formed cartilage
in the distal limb (Lescher et al., 1998). It was shown that
SFRP-2 is able to antagonize the activity of some canonical
Wnts during embryonic development (Lee et al., 2000). The
Sfrp-2 expressing CEF cells were grafted into the interdigit
area of wild-type limb bud or the distal mesenchyme of
Wnt-5a
 /  limb bud at 11.5 dpc and the limb buds were
culture for 3 d in vitro. We found that Sfrp-2 expressing
CEF cells induced ectopic expression of ColII, a marker for
differentiated chondrocytes, in both wild-type and Wnt-5a
 / 
limb buds (Fig. 5 D). These data demonstrate that suppres-
sion of canonical Wnt signaling allows distal chondrogenesis
to occur and rescues the limb phenotype of Wnt-5a
 /  em-
bryos to a certain extent.
To test whether Wnt-5a also regulates  -catenin protein
stability by controlling Siah2 expression during mouse limb
development, we compared the expression of Siah2 in wild-
type and Wnt-5a mutant embryos by whole mount in situ
hybridization. We found that Siah2 was expressed at very
low levels in the wild-type and Wnt-5a
 /  limb (unpub-
lished data), precluding accurate comparison.
Wnt-5a promotes  -catenin degradation 
in a colon cancer cell line
Because mutations that cause  -catenin stabilization are as-
sociated with the development of colon cancers and Wnt-5a
is expressed in the gut mesoderm (Lickert et al., 2001), we
first tested whether Wnt-5a can inhibit the accumulation of
 -catenin protein in the colon cancer cell line SW48, which
contains intact APC and a Ser 33 to Tyr missense mutation
in  -catenin that results in its stabilization. Wnt-5a expres-
sion led to reduced TOPFLASH reporter activity and de-
creased  -catenin protein levels (Fig. 6, A and B). Next, we
found that Siah2 was activated by Wnt-5a in the SW48 cells
(Fig. 6 C). Finally, we found that dominant negative forms
of Siah1 and 2 were able to block the activity of Wnt-5a in
degrading  -catenin (Fig. 6 B). In contrast, in the colon
Figure 5. Canonical Wnt signaling was 
increased in the Wnt-5a
 /  limb buds. 
Gene expression in embryos was examined 
by whole mount in situ hybridization. (A) 
At 12.5 dpc, the expression of Sox9, which 
marks early chondrogenesis, was not 
detected in the distal-most limb bud of the 
Wnt-5a
 /  limb (arrow). (B) Ectopic LacZ 
staining (arrow) was detected in the 
Wnt-5a
 / /TOPGAL distal limb at 12.5 dpc. 
(C) The  -catenin protein level was increased 
in the distal Wnt-5a
 /  limb at 11.5 dpc. 
(D) Sfrp-2 expressing cells (red), but not 
control cells (blue), induced ectopic expres-
sion of ColII (arrows), a marker for chon-
drocyte differentiation in both wild-type 
and Wnt-5a
 /  limbs.
Figure 6. Wnt-5a decreased  -catenin 
activity and protein stability in the 
SW48 cells but not in SW480 cells. 
(A) Wnt-5a expression inhibits TOPFLASH 
activity in SW48 cells. (B) Wnt-5a 
expression reduced the protein level 
of  -catenin in SW48 cells. Both  Siah1 
and  Siah2 blocked the activity of Wnt-5a 
in reducing  -catenin protein. (C) Wnt-5a 
also induces Siah2 expression in SW48 
cells. (D) Wnt-5a expression in SW480 
cells did not lead to the inhibition of 
 -catenin activity and protein degradation. 
Expression of APC inhibited  -catenin ac-
tivity and promoted  -catenin degradation.T
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cancer cell line SW480, which contains wild-type  -catenin
but no APC activity, expression of Wnt-5a did not lead to
inhibition of TOPFLAH activity or  -catenin degradation
(Fig. 6 D). These results are consistent with the conclusions
drawn from our experiments in 293 cells: the activity of
Wnt-5a in promoting  -catenin degradation requires Siah
and APC. Together, our findings show that Wnt-5a, in con-
trast to many other Wnts, signals through a novel pathway
that may involve the regulation of Siah2 expression to antag-
onize the canonical Wnt pathway in regulating embryonic
development and, possibly, in suppressing the formation of
a subset of tumors.
Discussion
Our results argue for a novel Wnt-5a signaling pathway that
antagonizes the canonical Wnt pathway by promoting
 -catenin degradation through the Siah–APC pathway,
rather than regulating the GSK-3– TrCP pathway.  -Cate-
nin is the key component that transduces the canonical Wnt
signal through its reduced degradation, which permits asso-
ciation with the transcription factors of the TCF family to
activate Wnt downstream target genes (van de Wetering et
al., 1997). Therefore, modulating  -catenin protein stability
has a profound impact on embryonic development and tu-
mor formation in which precise regulation of Wnt signaling
strength is required. Here, we show that in addition to se-
creted Wnt inhibitors such as Dickkopf and SFRP, Wnt-5a
signaling also plays an important role in modulating the sig-
naling strength of the canonical Wnt pathway in embryonic
development.
Wnt-5a promotes GSK-3–independent 
 -catenin degradation
One of our important findings is that Wnt-5a signaling can
promote   -catenin degradation by a GSK-3–independent
pathway. As the canonical Wnt pathway stabilizes  -catenin
degradation through inhibiting its phosphorylation by GSK-3,
our results are consistent with the previous observation that
Wnt-5a signals through a noncanonical pathway to inhibit
the canonical Wnt signaling activity in early Xenopus embryos
(Torres et al., 1996). However, it was not clear whether Wnt-
5a signaling directly inhibited components in the canonical
Wnt pathway or indirectly suppressed cellular response to ca-
nonical Wnts by altering cell adhesion. Furthermore, the
functional mechanism of Wnt-5a signaling in vivo was never
properly addressed in previous studies. Our data, together
with those obtained in Slusarski’s Lab (Westfall et al., 2003,
in this issue), demonstrated for the first time that at least part
of activities of Wnt-5a in vivo is to inhibit the canonical Wnt
signaling activity by promoting  -catenin degradation.
The canonical Wnt signaling can also up-regulate  -cate-
nin activity through a GSK-3–independent pathway in a
recently published work (Tolwinski et al., 2003). This
pathway depends on the degradation of Axin, which can se-
quester  -catenin in the cytoplasm. Because this pathway
appears to enhance  -catenin activity without affecting
 -catenin protein stability, it is unlikely that Wnt-5a signal-
ing inhibits the canonical Wnt signaling pathway through
interfering the interaction of LRP5/6, Axin, and  -catenin.
We propose that Wnt-5a signaling acts through a novel
pathway that requires Siah2/APC activity to modulate
 -catenin stability. Consistent with this, we found that
Siah2 expression can be up-regulated by Wnt-5a in 293 cells
(Fig. 4 E). However, Siah1 and 2 appear to have similar ac-
tivities in promoting  -catenin degradation and the domi-
nant negative Siah2 we used in this work blocks the protein
degradation pathway mediated by both Siah1 and 2. As the
Siah proteins exhibit functional redundancy and they pro-
mote the degradation of themselves, it is likely Siah1 is more
stable in the absence of Siah2 so that Siah2 function can be
largely compensated by Siah1 in Siah2
 /  mice (Hu and
Fearon, 1999). This may explain the lack of developmental
defects in Siah2
 /  mice (Frew et al., 2002). In that sense,
Wnt-5a might also regulate another factor that acts in the
Siah-mediated protein degradation pathway so that  -cate-
nin protein degradation defect is more severe in Wnt-5a
 / 
mutant embryos. Further investigation of Wnt-5a down-
stream targets will provide more insight into the molecular
mechanism of Wnt-5a in regulating  -catenin protein sta-
bility.
It is interesting to note that   -TrCP has much stronger
activity in up-regulating TOPFLASH activity and stabiliz-
ing  -catenin (Fig. 2, B and C) as compared with  Siah1,
 Siah2, and  APC (Fig. 2 B; Fig. 4, B and D) in nonstimu-
lated cells. These results indicate that  -catenin stability
is predominantly regulated by GSK-3– -TrCP pathway.
Wnt-5a may act through the Siah/APC pathway to modu-
late canonical Wnt pathway activation so that inappropriate
high activation of the canonical Wnt pathway is prevented.
Wnt-5a–induced  -catenin degradation 
and Ca
2  signaling
A revealing observation we made is that blocking CaMKII
or calcineurin activities with either a dominant negative con-
struct or specific pharmacological inhibitors did not block
the activity of Wnt-5a in  -catenin degradation, indicating
that activation of NF-AT or CaMKII is not required for the
activity of Wnt-5a in antagonizing the canonical Wnt path-
way. The previously identified downstream signaling events
of Wnt-5a such as activation of PKC and CaMKII appears
to have different effects in  -catenin degradation. PKC in-
creases   -catenin activity and protein stability, whereas
CaMKII decreases  -catenin activity. It is also interesting to
note that we did not detect significant activation of NF-AT
in response to Wnt-5a signaling. In addition, an activated
form of calcineurin had much stronger activity than Wnt-5a
in activating NF-AT transcriptional activity and yet its activ-
ity in inhibiting the TOPFLASH reporter was weaker than
Wnt-5a in 293 cells (Fig. 3, A and B). Although it was never
shown that a dominant negative NF-AT could rescue the
phenotype of Wnt-5a overexpression in the Xenopus embryo,
a constitutively active NF-AT was shown to enhance the
Wnt-5a overexpression phenotype (Saneyoshi et al., 2002).
These results can certainly be explained by Wnt-5a and NF-
AT acting in parallel pathways so they exhibit an additive ef-
fect. This is consistent with our finding in 293 and CHO
cells that NF-AT or CaMKII activation is sufficient but not
necessary in mediating Wnt-5a–induced  -catenin degrada-
tion, which may imply that Wnt-5a signals through theT
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combined effects of NF-AT and CaMKII activation in pro-
moting  -catenin degradation. In this case, one would ex-
pect that blocking either NF-AT or CaMKII activation
would result in partial rescue of the  -catenin activity and
protein stability inhibited by Wnt-5a. However, our obser-
vation that Wnt-5a–induced  -catenin inhibition was not
rescued by blocking NF-AT or CaMKII activation argues
that there may be a NF-AT– and CaMKII-independent
pathway that is activated by Wnt-5a signaling to promote
 -catenin degradation in 293 cells. Although this is our fa-
vored model, we could not rule the possibility that KN93
treatment or expression of a dominant negative CaMKII
only partially inhibited CaMKII activity. Therefore, CaMKII
activated by Wnt-5a was not sufficiently inhibited to allow
us to see the blockage of Wnt-5a activity. It is also possible
that the abundance of some signaling components in these
parallel pathways may rely on specific cellular context, which
will determine that the dominant pathways in mediating
Wnt-5a–induced   -catenin degradation vary in different
cells, tissues, and organisms.
It was reported recently that CaMKII mediates the activ-
ity of Wnt-5a in inhibiting canonical Wnt activity without
affecting  -catenin protein stability in 293 cells (Ishitani et
al., 2003), which disagrees with what we have observed in a
large number of different cell lines. The difference may sim-
ply result from heterogeneity of 293 cells used in different
research groups. Our in vivo observation that  -catenin sta-
bility was increased in the Wnt-5a
 /  limb strongly supports
the role of Wnt-5a in promoting  -catenin degradation.
However, it is possible that Wnt-5a signals through both
 -catenin degradation and CaMKII-activated phosphoryla-
tion of TCF transcription factors in inhibiting the canonical
Wnt pathway. Genetic manipulation of CaMKII activity in
a particular developmental process, for instance, limb devel-
opment, will be necessary to directly access the role of
CaMKII in Wnt-5a and the canonical Wnt signaling. Such
studies will be important in understanding the mechanism
of Wnt signaling not only in embryonic development but
also in postembryonic physiological processes where Ca
2 
signaling plays a critical role such as learning and memory
and lymphocyte development and activation (Soderling et
al., 2001; Crabtree and Olson, 2002).
The role of Wnt-5a in regulating limb development 
and tumor formation
Consistent with our findings in vitro, we found that loss of
Wnt-5a function led to increased canonical Wnt signaling
activity in the distal limb by directly assessing the canoni-
cal Wnt signaling activity in vivo in the Wnt-5a
 /  limb
using TOPGAL mice (DasGupta and Fuchs, 1999). Two
lines of evidence support our conclusion that inhibited
chondrogenesis in the Wnt-5a
 /  limb bud results from
up-regulated canonical Wnt activity. First, it has been
shown both in vivo and in vitro that increased  -catenin
activity leads to inhibition of chondrogenesis (Ryu et al.,
2002). Second, SFRP-2, a secreted Wnt inhibitor was able
to rescue chondrogenesis in the Wnt-5a
 /  limb bud (Fig.
5 D). This implies that one important function of Wnt-5a,
which is expressed at the highest level in the distal limb, is
to inhibit the canonical Wnt activity to allow chondrogen-
esis to occur in the distal limb bud. The high canonical
Wnt activity in the distal limb may come from the ecto-
derm and AER, which express many Wnt family members
(Parr et al., 1993). Consistent with this, it has been shown
that the limb ectoderm and AER exhibit strong activity in
inhibiting chondrogenesis (Solursh et al., 1981). As SFRP-2
is also able to induce chondrogenesis in the interdigit area
of the wild-type limb bud, the canonical Wnt activity is
high in both the interdigit area and the distal limb. The ca-
nonical Wnt activity in the interdigit area may come from
Wnt-14, which is expressed in the interdigit area and has
activity similar to  -catenin in inhibiting chondrogenesis
(Hartmann and Tabin, 2001).
It has been shown that cell proliferation is reduced in the
distal limb bud of the Wnt-5a
 /  embryos at the time of
chondrogenesis (Yamaguchi et al., 1999). However, we do
not think decreased cell proliferation per se in the Wnt-5a
 / 
limb bud results in failure of chondrogenesis because cell
condensation before chondrocyte differentiation is not due
to increased cell proliferation, rather, it is a process of cell ag-
gregation, which involves alterations in cell adhesion and
migration (Thorogood and Hinchliffe, 1975). In fact, cell
proliferation in the condensing mesenchyme is drastically re-
duced and increasing cell proliferation does not affect chon-
drocyte differentiation (Rossi et al., 2002). Moreover, it has
been shown that TGF  inhibits cell proliferation and yet it
strongly promotes chondrocyte differentiation (Shukunami
et al., 1998). As noncanonical Wnt signaling has been impli-
cated in the regulation of cytoskeleton rearrangement (Ha-
bas et al., 2001), which may cause changes in cell adhesion
and migration during mesenchymal condensation, it will be
interesting to further investigate whether Wnt-5a also con-
trols chondrocyte differentiation through regulating cyto-
skeleton rearrangement.
Our finding that Wnt-5a signaling promotes GSK-3–
independent   -catenin degradation suggests that Wnt-5a
may play a role as an oncosuppressor. Wnt-5a is expressed in
the mesenchymal layer of the gut (Lickert et al., 2001) that
can signal to the epithelium where tumors arise. Because the
activity of Wnt-5a requires APC, it is likely that mutations
in Wnt-5a will have a synergistic effect with gain of function
mutations in  -catenin or loss of function mutations in
APC in colon cancer development. On the other hand, up-
regulating Wnt-5a may prevent tumor formation in cells
that has stabilized  -catenin and intact APC, but not in cells
that contain loss of function mutations in APC as indicated
by our experiments in SW48 and SW480 cells (Fig. 6). Fur-
ther testing these hypotheses with genetic approaches will
provide more insight into the processes of intestinal tumor
formation.
Materials and methods
Generation of TOPGAL transgenic mice and in situ hybridization
The TOPGAL Transgenic mice were generated as described previously
(DasGupta and Fuchs, 1999). Mouse embryos were dissected in PBS. For
LacZ staining, embryos were fixed in 0.5% formaldehyde and 0.5% glutar-
aldehyde for 10 min at room temperature. For in situ hybridizations, em-
bryos were fixed in 4% formaldehyde at 4 C overnight. Whole mount in
situ hybridization was performed as described previously (Yang et al.,
1998). RNA probes were described previously: Sox9 (Zhao et al., 1997)
and ColII (Lee et al., 1996).T
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Plasmids
The coding regions of Wnt-5a and Wnt-3a were inserted into pIRES-
hrGFP-1a expression vector (Stratagene) and pCDNA3 (Invitrogen), respec-
tively. The TCF reporter plasmid Kit including TOPFLASH and FOPFLASH
plasmids was purchased from Upstate Biotechnology. The wild-type and a
mutant human  -catenin with a Ser to Ala point mutation at the amino
acid 37 (Zorn et al., 1999), provided by Y. Li (Baylor College of Medicine,
Houston, TX), were inserted into the pIRES-hGFP-1 expression vector. A
mutant form of  -catenin that lacks amino acids 29–48 (  -catenin; pro-
vided by F. McCormick, University of California, San Francisco, CA) was
PCR amplified and cloned into pIRES-hGFP-1a. The dominant negative hu-
man APC (2543–2843) was constructed by PCR as described previously
(Liu et al., 2001) and subcloned into pIRES-hrGFP-1a. The human Siah1
and 2 expression constructs were purchased as EST clones (I.M.A.G.E.
947650 and 5749927). The coding region of Sfrp-2 was subcloned into the
RCAS vector (Hughes et al., 1987) to generate Sfrp-2-RCAS. The dominant
negative mouse Siah-1 ( Siah 297–298) was amplified by PCR with prim-
ers M N-SIAH1F (CGGAATTCACCATGCCTTGTAAATATGCCTCTTCTG)
and M N-SIAH1R (CCGCTCGAGTCAACACATGGAAATAGTTACATTG),
and cloned into pIRES-hGFP-1a. A dominant negative human Siah2
( Siah2) was constructed by PCR using the primers Siah2–268 and Siah2–
691 (5 -CCTATTCTGCAGTGCCAGGC-3  and 5 -CTCTTGTTTCTCCAG-
CACCAG-3 ). The plasmids containing the full length of  -TrCP or a domi-
nant negative  -TrCP were provided by Z.J. Chen (The University of
Texas Southwestern Medical Center, Dallas, TX). The constructs for consti-
tutively active and dominant negative CaMKII were provided by R. Moon
(University of Washington School of Medicine, Seattle, WA). D. Bohmann
provided the c-Jun expression vector (University of Rochester, Roches-
ter, NY).
Limb cultures
Mouse limbs were dissected from 11.5- or 12.5-dpc embryos in PBS. Con-
trol CEF cell pellets or CEF cell pellets transfected with Sfrp-2-RCAS DNA
were inserted into the interdigit region of wild-type limbs or the distal re-
gion of the Wnt-5a
 /  limbs. The limbs were cultured as previously de-
scribed (Storm and Kingsley, 1999).
Cell culture, transfection, and nucleofection
NIH3T3, CHO, 293, and HeLa cell lines were obtained from American
Type Culture Collection. Rat chondrosarcoma cells were obtained from
Y. Yamada (National Institutes of Health, Bethesda, MD). Cells were
seeded the day before transfection and transfected with the indicated
plasmids using LipofectAMINE PLUS as specified by the manufacturer
(Invitrogen). In luciferase assays, cells were transfected with a reporter
construct (TOPFLASH, FOPFLASH, or NF-AT reporter), an internal con-
trol (pRLSV40 or phRL-null, obtained from Promega) and indicated plas-
mids in 6-well plates. The total amount of transfected DNA was kept
constant by adding empty vector DNA. Luciferase activity was measured
at indicated time after transfection according to the Dual-Luciferase Re-
porter Assay System (Promega). The results are shown as relative lu-
ciferase activity. The histograms are presented as the average   SD from
three independent transfections. For Western and gene expression analy-
sis, cells were transfected in 60-mm plates. A special electroporation ap-
paratus with the Nucleofector technology (Amaxa GmbH) was used to
achieve high transfection efficiency in the SW 48 and SW480 cells. Sfrp-
2-RCAS DNA was transfected into CEF cells and the transfected cells
were split 2 d later. 2 d after the cells were split, they were harvested and
cell pellets were generated according to a procedure described previ-
ously (Yang and Niswander, 1995).
Western blot analysis
Mouse embryos were collected at 11.5 d after coitum (dpc). Distal limb
bud tissues were dissected from wild-type and Wnt-5a
 /  embryos,
washed in PBS, and frozen on dry ice. The frozen limb samples were
boiled for 10 min in 2 NuPAGE LDS sample buffer. Cells were washed in
PBS and lysed in boiling 2 NuPAGE LDS sample buffer and treated as de-
scribed previously (Topol et al., 2000). Total proteins were separated by
4–12% Bis-Tris NuPAGE (Invitrogen) and transferred to Hybond ECL nitro-
cellulose membrane (Amersham Biosciences). The membranes were
probed with primary antibodies, followed by HRP-conjugated secondary
antibodies at 1:30,000 (Amersham Biosciences), and developed using
chemiluminescent substrates (Pierce Chemical Co.). Primary antibodies
used in this work: anti– -catenin (Transduction Labs), anti– -tubulin (ICN
Biomedicals) anti–Phospho-PKC kit (Cell Signaling Technology), anti-acti-
vated CaMKII (Promega), and anti–phospho-c-jun (Ser 63) and anti–c-Jun
(Cell Signaling Technology) antibodies.
Treatment with pharmacological inhibitors
CsA was used to inhibit calcineurin at 1  M and KN 93 was used to inhibit
CaMKII at 25  M. 24 h after transfection, inhibitors were added. After 16 h
of incubation with the inhibitors, cells were lysed for luciferase assay or
Western analysis.
RNA isolation and RT-PCR
Total RNA was extracted using RNA-Bee (Test-Tel, Inc.) according to the
manufacture’s instructions and analyzed with RT-PCR using one-step RT-
PCR kit (QIAGEN). Endogenous mouse Siah1 was detected using the fol-
lowing primers: mSiah1fwd, 5 -GGCAATCAAATATTTCTGGCC-3 ; and
mSiah1rev, 5 -CACGCATGCGTGCACAGAC-3 . For endogenous mouse
Siah2, the following primers were used: 5 -GCATAGCGCTCTCTATGTT-
TAATA-3  and 5 -GCTCAACTCTGTTGATTCTCT-3 . To detect endoge-
nous human Siah1, the following primers were used: huSiah1fwd, 5 -CGG-
AATTCACCATGCCCTGTAAATATGCGTCTTCTG-3 ; and huSiah1rev,
5 -CCGCTCGAGTCAACACATGGAAATAGTTACATT-3 . Human Siah2
was detected with primers: 5 -GCTAATAAACCCTGCAGCAA-3  and 5 -
ACTTCTGGCGGCATTGGTTA-3 . GAPDH was detected using the follow-
ing primers: forward, 5 -ACCACAGTCCATGCCATCAC-3 ; and reverse,
5 -TCCACCACCCTGTTGCTGTA-3 .
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